This website uses cookies to provide you with the best experience. By using this site you agree to our use of cookies. Please read our cookie notice for more information.

« Back

ICON reports 48% increase in revenue and 46% increase in operating income and raises guidance for 2008

April 29, 2008

ICON reports 48% increase in revenue and 46% increase in operating income and raises guidance for 2008 (NASDAQ:ICLR)

Highlights – First Quarter Fiscal 2008

  • First quarter net revenues increased 48% over the comparative quarter, to $201.3 million.

  • Income from operations increased by 46%, to $21.5 million.

  • Diluted earnings per share increased by 33%, to 56 cents.
  • Record $369 million of net new business wins in the quarter, representing a book-to-bill ratio of 1.8.

  • 2008 Guidance for revenue and EPS increased to $840 - $860 million and $2.35 - $2.45 respectively.

Dublin, Ireland, April 29, 2008 – ICON (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter ended March 31, 2008.

Net revenues for the quarter were $201.3 million, representing a 48% increase over net revenues of $136.1 million for the comparative quarter last year. 

Income from operations was $21.5 million or 10.7% of revenue, compared to $14.7 million or 10.8% for the same quarter last year. Net income was $16.9 million or 56 cents per share on a diluted basis, compared with $12.3 million or 42 cents per share last year.

Days sales outstanding, comprising accounts receivable and unbilled revenue less payments on account, were 67 days at March 31, 2008, compared to 66 days at December 31, 2007.

For the quarter ended March 31, 2008, cash used in operating activities was $12.3 million and capital expenditure was $16.5 million.  We completed the acquisition of HCD a phase I unit based in San Antonio, Texas on February 11thfor a net consideration of $11 million. As a result, the company's net debt, amounted to $20.2 million at March 31, 2008, compared to net cash and short-term investments of $23.8 million at December 31, 2007. 

“It has been an excellent start to 2008”, commented Chairman Dr. John Climax “Both revenue and operating income showed substantial growth. Business wins were again strong with $369 million of net business awarded in the quarter.  Accordingly we are raising our 2008 guidance for revenue and EPS to $840 - $860 million and $2.35 - $2.45 respectively.”

The company will hold its first quarter conference call today, April 29, 2008 at 10:00 EST [15:00 Ireland & UK].  This call and linked slide presentation can be accessed live from our website at www.iconplc.com  A recording will also be available on the website for 90 days following the call.  In addition, a calendar of company events, including upcoming conference presentations, is available on our website, under “Investors”.  This calendar will be updated regularly.

The statements made in this Press Release may contain forward-looking statements that involve a number of risks and uncertainties. In addition to the matters described in this Press Release, the ability to maintain large client contracts or enter into new contracts, maintain client relationships and the ability to manage the opening of new offices, the integration of new business mergers and acquisitions, as well as other risks and uncertainties detailed from time to time in SEC reports filed by ICON, including its Form 20-F, F-1, S-8 and F-3, may affect the actual results achieved by ICON. ICON disclaims any intent or obligation to update these forward-looking statements.

The financial information presented herein has been prepared in accordance with U.S. GAAP.

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON teams have successfully conducted over 1,900 development projects and over 2,300 consultancy engagements across all major therapeutic areas. ICON currently has approximately 6,150 employees, operating from 69 locations in 36 countries. Further information is available at www.iconplc.com

Source: ICON plc

Contact : Investor Relations 1-888-381-7923 or

Ciaran Murray CFO + 353 –1-291-2000

Both at ICON.

ICON plc

Consolidated Income Statements (Unaudited)

Three  Months ended March 31, 2008 and March 31, 2007

(Dollars, in thousands, except share and per share data)

Three Months Ended

March 31,

March 31,

2008

2007

Gross Revenue

283,853

186,740

Subcontractor costs

82,509

50,651

Net Revenue

201,344

136,089

Costs and expenses

Direct costs

113,189

78,557

Selling, general and administrative

60,545

38,684

Depreciation and amortization

6,098

4,156

Total costs and expenses

179,832

121,397

Income from operations

21,512

14,692

Net interest (expense) / income

(43)

1,044

Income before provision for income taxes

21,469

15,736

Provision for income taxes

4,247

3,428

Minority interest

328

42

Net income

16,894

12,266

Net income per ordinary share

Basic

$0.58

$0.43

Diluted

$0.56

$0.42

Weighted average number of ordinary shares

Basic

28,902,630

28,564,498

Diluted

30,039,736

29,508,662

ICON plc

Summary Balance Sheet Data

March 31, 2008 and December 31, 2007

(Dollars, in thousands)

March 31,

December 31,

2008

2007

(Unaudited)

(Audited)

Cash and short-term investments

110,965

118,633

Debt

(131,147)

(94,829)

Net (debt)/cash

(20,182)

23,804

Accounts receivable

182,672

129,865

Unbilled revenue

161,120

144,661

Payments on account

(133,805)

(96,553)

Total

209,987

177,973

Working Capital

189,805

193,271

Total Assets

797,880

693,138

Shareholder's Equity

421,033

388,400

Source:

ICON plc

Contact:

Investor Relations 1-888-381-7923 or

Ciaran Murray CFO + 353 1 291 2000

both at ICON.

http://www.iconplc.com



 



Back to press releases


Search Investor